M.B. Khazaeli - Concepedia

Author

M.B. Khazaeli

Also Known As

Khazaeli, Mohammad Bagher, M B Khazaeli, M KHAZAELI, M. B Khazaeli, M. B. Khazaeli, M. Khazaeli, M.B Khazaeli, M.B. KHAZAELI, M.B. Khazaeli, M.B. Khazaeli,

101

Publications

5.5K

Citations

H-Index

111

Concepts

All Affiliations

University of Alabama at Birmingham Birmingham VA Medical Center United States Department of Veterans Affairs University of Michigan

About

M.B. Khazaeli is an author at University of Alabama at Birmingham specializing in medicine, oncology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	32	2.4K
2	Engineering	4	4	158
3	Health Sciences	4	4	295
4	Natural Sciences	2	2	319
5	Public Health	1	1	34

M.B. Khazaeli

Publications

5.1K

Citations

H-Index

Page 1

	Year	Citations
Mouse/human chimeric monoclonal antibody in man: kinetics and immune response. Albert F. LoBuglio, Richard Wheeler, J M Trang, Proceedings of the National Academy of Sciences Immunocytochemical TechniqueOncologyAllergyMurine 17-1A MabMedicine	1989	526
Phase I Study of Anti–Epidermal Growth Factor Receptor Antibody Cetuximab in Combination With Radiation Therapy in Patients With Advanced Head and Neck Cancer Francisco Robert, Mark P. Ezekiel, Sharon A. Spencer, Journal of Clinical Oncology	2001	473
Use of chlorotoxin for targeting of primary brain tumors. Liliana Soroceanu, M.B. Khazaeli, Harald Sontheimer PubMed Brain-associated RadioactivityToxinologyImmunologyMolecular BiologyGlioma	1998	237
Phase I Single-Dose Study of Intracavitary-Administered Iodine-131-TM-601 in Adults With Recurrent High-Grade Glioma Adam N. Mamelak, Steven S. Rosenfeld, Richard D. Bucholz, Journal of Clinical Oncology	2006	215
A Pilot Trial of Vitaxin, A Humanized Anti-Vitronectin Receptor (anti <i>α</i> <sub>v</sub> <i>β</i> <sub>3</sub> ) Antibody in Patients with Metastatic Cancer James Posey, M.B. Khazaeli, Alma Delgrosso, Cancer Biotherapy and Radiopharmaceuticals	2001	190
Intraperitoneal Radioimmunotherapy of Ovarian Cancer with177Lu-CC49: A Phase I/II Study Ronald D. Alvarez, Edward E. Partridge, M.B. Khazaeli, Gynecologic Oncology Tumoral PathologyMalignant DiseaseMedicinePathologyOvarian Cancer With177lu-cc49	1997	178
Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma. M N Saleh, M.B. Khazaeli, Richard Wheeler, PubMed ImmunologyPharmacotherapyImmunotherapyMurine 14G2aNeuro-oncology	1992	160
Treatment of metastatic prostate carcinoma with radiolabeled antibody CC49. Ruby F. Meredith, Anton J. Bueschen, M.B. Khazaeli, PubMed	1994	127
Phase I Trial of Multiple Large Doses of Murine Monoclonal Antibody CO17-1A. II. Pharmacokinetics and Immune Response1 M.B. Khazaeli, MN Saleh, Richard Wheeler, JNCI Journal of the National Cancer Institute ImmunodeficienciesImmunologyFourth InfusionImmunodominanceAntibody Response	1988	122
A phase I study of anti-kinase insert domain-containing receptor antibody, IMC-1C11, in patients with liver metastases from colorectal carcinoma. James Posey, Thian C. Ng, Baolian Yang, PubMed	2003	121

Page 1